EP3713583C0 - Verfahren und zusammensetzungen zur behandlung der haut - Google Patents

Verfahren und zusammensetzungen zur behandlung der haut

Info

Publication number
EP3713583C0
EP3713583C0 EP18881031.1A EP18881031A EP3713583C0 EP 3713583 C0 EP3713583 C0 EP 3713583C0 EP 18881031 A EP18881031 A EP 18881031A EP 3713583 C0 EP3713583 C0 EP 3713583C0
Authority
EP
European Patent Office
Prior art keywords
skin
compositions
treatment
methods
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
EP18881031.1A
Other languages
English (en)
French (fr)
Other versions
EP3713583A4 (de
EP3713583B1 (de
EP3713583A1 (de
Inventor
Burt R Shaffer
Steven M Hernandez
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Topix Pharmaceuticals Inc
Original Assignee
Topix Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Topix Pharmaceuticals Inc filed Critical Topix Pharmaceuticals Inc
Priority to EP25153177.8A priority Critical patent/EP4552650A3/de
Publication of EP3713583A1 publication Critical patent/EP3713583A1/de
Publication of EP3713583A4 publication Critical patent/EP3713583A4/de
Application granted granted Critical
Publication of EP3713583B1 publication Critical patent/EP3713583B1/de
Publication of EP3713583C0 publication Critical patent/EP3713583C0/de
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/16—Amides, e.g. hydroxamic acids
    • A61K31/17—Amides, e.g. hydroxamic acids having the group >N—C(O)—N< or >N—C(S)—N<, e.g. urea, thiourea, carmustine
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
    • A61K31/19—Carboxylic acids, e.g. valproic acid
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/12—Carboxylic acids; Salts or anhydrides thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/14—Esters of carboxylic acids, e.g. fatty acid monoglycerides, medium-chain triglycerides, parabens or PEG fatty acid esters
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/24—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing atoms other than carbon, hydrogen, oxygen, halogen, nitrogen or sulfur, e.g. cyclomethicone or phospholipids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/02—Cosmetics or similar toiletry preparations characterised by special physical form
    • A61K8/04—Dispersions; Emulsions
    • A61K8/06—Emulsions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
    • A61K8/36—Carboxylic acids; Salts or anhydrides thereof
    • A61K8/365—Hydroxycarboxylic acids; Ketocarboxylic acids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
    • A61K8/42—Amides
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/06—Ointments; Bases therefor; Other semi-solid forms, e.g. creams, sticks, gels
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin
    • A61Q19/007—Preparations for dry skin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/10—Dispersions; Emulsions
    • A61K9/127—Synthetic bilayered vehicles, e.g. liposomes or liposomes with cholesterol as the only non-phosphatidyl surfactant

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Dermatology (AREA)
  • Birds (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Emergency Medicine (AREA)
  • Molecular Biology (AREA)
  • Biophysics (AREA)
  • Dispersion Chemistry (AREA)
  • Cosmetics (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
EP18881031.1A 2017-11-21 2018-11-21 Verfahren und zusammensetzungen zur behandlung der haut Active EP3713583B1 (de)

Priority Applications (1)

Application Number Priority Date Filing Date Title
EP25153177.8A EP4552650A3 (de) 2017-11-21 2018-11-21 Verfahren und zusammensetzungen zur behandlung der haut

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US201762589552P 2017-11-21 2017-11-21
PCT/US2018/062320 WO2019104222A1 (en) 2017-11-21 2018-11-21 Methods and compositions for treatment of skin

Related Child Applications (1)

Application Number Title Priority Date Filing Date
EP25153177.8A Division EP4552650A3 (de) 2017-11-21 2018-11-21 Verfahren und zusammensetzungen zur behandlung der haut

Publications (4)

Publication Number Publication Date
EP3713583A1 EP3713583A1 (de) 2020-09-30
EP3713583A4 EP3713583A4 (de) 2021-06-30
EP3713583B1 EP3713583B1 (de) 2025-01-22
EP3713583C0 true EP3713583C0 (de) 2025-01-22

Family

ID=66534309

Family Applications (2)

Application Number Title Priority Date Filing Date
EP18881031.1A Active EP3713583B1 (de) 2017-11-21 2018-11-21 Verfahren und zusammensetzungen zur behandlung der haut
EP25153177.8A Pending EP4552650A3 (de) 2017-11-21 2018-11-21 Verfahren und zusammensetzungen zur behandlung der haut

Family Applications After (1)

Application Number Title Priority Date Filing Date
EP25153177.8A Pending EP4552650A3 (de) 2017-11-21 2018-11-21 Verfahren und zusammensetzungen zur behandlung der haut

Country Status (4)

Country Link
US (1) US12440432B2 (de)
EP (2) EP3713583B1 (de)
CN (1) CN111372595A (de)
WO (1) WO2019104222A1 (de)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2021255734A1 (en) 2020-04-16 2022-11-24 Mf Beauty Partners Llc Stabilizing vitamin C application formulations
AU2021256054A1 (en) 2020-04-16 2022-11-24 Mf Beauty Partners Llc High-potency vitamin C and sugar alcohol topical formulations
TW202203912A (zh) * 2020-04-16 2022-02-01 美商百克醫療股份有限公司 非水性局部調配物
EP4225290A4 (de) * 2020-10-09 2024-11-27 Topix Pharmaceuticals, Inc. Verfahren und zusammensetzungen für therapeutische hautbehandlungen bei dermatologischen eingriffen mit auswirkung auf die hautbarriere
CN116782923A (zh) * 2020-11-25 2023-09-19 塔普克斯制药公司 疤痕治疗组合物
US20240108556A1 (en) * 2020-11-25 2024-04-04 Topix Pharmaceuticals, Inc. Scar treatment composition
CN114042011A (zh) * 2021-11-30 2022-02-15 无锡知妍生物科技有限公司 一种用于改善毛周角化的身体修护乳及制备方法
CN116211725A (zh) * 2022-12-13 2023-06-06 无锡知妍生物科技有限公司 一种洗去类高浓度尿素去角质凝胶及其制备方法

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3231472A (en) * 1961-03-10 1966-01-25 Kolmar Laboratories Method of increasing water-absorbing ability of human skin and composition therefor
RU2038073C1 (ru) 1992-02-03 1995-06-27 Любовь Степановна Ермолова Крем для ухода за кожей лица и шеи
WO1994021216A1 (en) * 1993-03-19 1994-09-29 Handelman, Joseph, H. Topical composition for inhibiting hair growth
US5571503A (en) * 1995-08-01 1996-11-05 Mausner; Jack Anti-pollution cosmetic composition
EP1492486A2 (de) * 2002-04-10 2005-01-05 Ruey J. Dr. Yu Harnstoff-zusammensetzungen
US7785584B2 (en) * 2003-08-13 2010-08-31 Healthpoint, Ltd. Ointment wound spray
US20060110415A1 (en) * 2004-11-22 2006-05-25 Bioderm Research Topical Delivery System for Cosmetic and Pharmaceutical Agents
US20070248555A1 (en) * 2006-04-20 2007-10-25 Watson Dana M Composition and method for managing redness of skin associated with dermatological condition
DE102006056320A1 (de) * 2006-11-21 2008-05-29 Beiersdorf Ag Kosmetische Formulierung mit Glucosylglyceriden und ausgewählten Parfümstoffen
GB2478159A (en) 2010-02-26 2011-08-31 Lrc Products Composition for the treatment of fungal nail infection
US9492407B2 (en) 2011-05-12 2016-11-15 Auxilium Cura Innovatio Topical formulation for treatment of hyperkeratotic skin
DE102011089612A1 (de) * 2011-12-22 2013-06-27 Henkel Ag & Co. Kgaa Körperpflegemittel mit verbesserter Hautfeuchte
RU2496476C1 (ru) 2012-08-10 2013-10-27 Федеральное государственное бюджетное учреждение "Уральский научно-исследовательский институт дерматовенерологии и иммунопатологии" Министерства здравоохранения и социального развития Российской Федерации (ФГБУ "УрНИИДВиИ" Минздравсоцразвития России) Средство наружной терапии для больных атопическим дерматитом
US9399009B1 (en) 2012-10-05 2016-07-26 Clark Pharmaceuticals, Llc Composition and method of treating skin conditions
FR2997406B1 (fr) * 2012-10-25 2015-07-03 Basf Beauty Care Solutions F Polymere de hyaluronate et de glucomannane
US9168283B2 (en) * 2012-12-11 2015-10-27 Avon Products, Inc. Medemia nobilis extracts and methods of use
WO2014140507A1 (en) * 2013-03-15 2014-09-18 Moberg Pharma Ab Pharmaceutical composition for the treatment of fungal infections
US10092491B2 (en) 2015-03-20 2018-10-09 John E. Kulesza Skin renewal enhancer
RU2622020C1 (ru) 2016-07-15 2017-06-08 Максим Львович Тютиков Комплексная косметическая композиция для ухода за кожей

Also Published As

Publication number Publication date
US12440432B2 (en) 2025-10-14
EP4552650A3 (de) 2025-08-13
WO2019104222A1 (en) 2019-05-31
EP4552650A2 (de) 2025-05-14
EP3713583A4 (de) 2021-06-30
CN111372595A (zh) 2020-07-03
EP3713583B1 (de) 2025-01-22
US20190151214A1 (en) 2019-05-23
EP3713583A1 (de) 2020-09-30

Similar Documents

Publication Publication Date Title
EP3675882A4 (de) Verfahren und zusammensetzungen zur behandlung von erkrankungen im zusammenhang mit mikrobiomen
EP3645739A4 (de) Verfahren und zusammensetzungen zur behandlung von melanom
EP3576776A4 (de) Zusammensetzungen und verfahren zur behandlung von herzfehlern
EP3716767A4 (de) Verfahren und zusammensetzungen zur behandlung von seltenen erkrankungen
EP3713583C0 (de) Verfahren und zusammensetzungen zur behandlung der haut
EP3612215A4 (de) Zusammensetzungen und verfahren zur behandlung von lungenentzündungen
EP3585817A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3538119A4 (de) Zusammensetzungen und verfahren zur behandlung von hauterkrankungen und bewahrung von gesunder haut
EP3826666A4 (de) Zusammensetzungen und verfahren zur behandlung von nrp2-assoziierten erkrankungen
EP3655534C0 (de) Zusammensetzungen und verfahren zur behandlung von beta-hämoglobinopathien
EP3600285A4 (de) Topische zusammensetzungen und verfahren zur behandlung
EP3484526A4 (de) Zusammensetzungen und verfahren zur behandlung von herzkrankheiten
EP3558279A4 (de) Zusammensetzungen und verfahren zur behandlung chronischer schmerzen
EP3612222A4 (de) Zusammensetzungen und verfahren zur behandlung von krebs
EP3592345A4 (de) Zusammensetzungen und verfahren zur behandlung von entzündungskrankheiten
EP3139928C0 (de) Anordrin-zusammensetzungen und verfahren zur behandlung von krankheiten
EP3436157C0 (de) Verfahren und zusammensetzungen zur behandlung von hautleiden
EP3600302A4 (de) Verfahren und zusammensetzungen zur behandlung von krebs
EP3681871A4 (de) Zusammensetzungen und verfahren zur behandlung von hirnverletzungen
EP3582802A4 (de) Verfahren und zusammensetzungen zur behandlung von hirnläsionen
EP3589283A4 (de) Verfahren und zusammensetzung zur behandlung von essstörungen
EP3675871A4 (de) Zusammensetzungen und verfahren zur behandlung von fibrotischen krankheiten
EP3740592A4 (de) Verfahren und zusammensetzungen zur behandlung von gefässerkrankungen
EP3902605A4 (de) Verfahren und zusammensetzungen zur behandlung von haut- und haarerkrankungen
EP3664813A4 (de) Zusammensetzungen und verfahren zur behandlung mit nicotinamid-mononukleotid

Legal Events

Date Code Title Description
STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE INTERNATIONAL PUBLICATION HAS BEEN MADE

PUAI Public reference made under article 153(3) epc to a published international application that has entered the european phase

Free format text: ORIGINAL CODE: 0009012

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: REQUEST FOR EXAMINATION WAS MADE

17P Request for examination filed

Effective date: 20200622

AK Designated contracting states

Kind code of ref document: A1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

AX Request for extension of the european patent

Extension state: BA ME

DAV Request for validation of the european patent (deleted)
DAX Request for extension of the european patent (deleted)
REG Reference to a national code

Ref country code: HK

Ref legal event code: DE

Ref document number: 40038584

Country of ref document: HK

A4 Supplementary search report drawn up and despatched

Effective date: 20210601

RIC1 Information provided on ipc code assigned before grant

Ipc: A61K 31/728 20060101AFI20210526BHEP

Ipc: A61K 31/17 20060101ALI20210526BHEP

Ipc: A61K 31/19 20060101ALI20210526BHEP

Ipc: A61K 47/36 20060101ALI20210526BHEP

Ipc: A61K 47/10 20170101ALI20210526BHEP

Ipc: A61K 8/365 20060101ALI20210526BHEP

Ipc: A61K 9/06 20060101ALI20210526BHEP

Ipc: A61K 8/42 20060101ALI20210526BHEP

Ipc: A61P 17/00 20060101ALI20210526BHEP

Ipc: A61Q 19/00 20060101ALI20210526BHEP

Ipc: A61K 47/12 20060101ALI20210526BHEP

Ipc: A61K 47/24 20060101ALI20210526BHEP

Ipc: A61K 47/14 20170101ALI20210526BHEP

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: EXAMINATION IS IN PROGRESS

17Q First examination report despatched

Effective date: 20221114

GRAP Despatch of communication of intention to grant a patent

Free format text: ORIGINAL CODE: EPIDOSNIGR1

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: GRANT OF PATENT IS INTENDED

INTG Intention to grant announced

Effective date: 20240903

GRAS Grant fee paid

Free format text: ORIGINAL CODE: EPIDOSNIGR3

GRAA (expected) grant

Free format text: ORIGINAL CODE: 0009210

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: THE PATENT HAS BEEN GRANTED

AK Designated contracting states

Kind code of ref document: B1

Designated state(s): AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR

REG Reference to a national code

Ref country code: GB

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: CH

Ref legal event code: EP

REG Reference to a national code

Ref country code: IE

Ref legal event code: FG4D

REG Reference to a national code

Ref country code: DE

Ref legal event code: R096

Ref document number: 602018078754

Country of ref document: DE

U01 Request for unitary effect filed

Effective date: 20250224

U07 Unitary effect registered

Designated state(s): AT BE BG DE DK EE FI FR IT LT LU LV MT NL PT RO SE SI

Effective date: 20250228

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: RS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: PL

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: ES

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: IS

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250522

Ref country code: NO

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250422

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: HR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: GR

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250423

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SM

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: CZ

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250122

PG25 Lapsed in a contracting state [announced via postgrant information from national office to epo]

Ref country code: SK

Free format text: LAPSE BECAUSE OF FAILURE TO SUBMIT A TRANSLATION OF THE DESCRIPTION OR TO PAY THE FEE WITHIN THE PRESCRIBED TIME-LIMIT

Effective date: 20250122

PLBE No opposition filed within time limit

Free format text: ORIGINAL CODE: 0009261

STAA Information on the status of an ep patent application or granted ep patent

Free format text: STATUS: NO OPPOSITION FILED WITHIN TIME LIMIT

REG Reference to a national code

Ref country code: CH

Ref legal event code: U11

Free format text: ST27 STATUS EVENT CODE: U-0-0-U10-U11 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20251201

REG Reference to a national code

Ref country code: CH

Ref legal event code: L10

Free format text: ST27 STATUS EVENT CODE: U-0-0-L10-L00 (AS PROVIDED BY THE NATIONAL OFFICE)

Effective date: 20251203